Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics

Background: Nucleic acid-amplified tests for Chlamydia trachomatis are accurate but costly. Screening strategies for asymptomatic men are needed. Goal: To assess C trachomatis screening strategies for asymptomatic males. Study Design: Men attending a sexually transmitted disease clinic were tested f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sexually transmitted diseases 2001-04, Vol.28 (4), p.219-225
Hauptverfasser: MARRAZZO, JEANNE M., WHITTINGTON, WILLIAM L. H., CELUM, CONNIE L., HANDSFIELD, H. HUNTER, CLARK, AGNES, CLES, LINDA, KREKELER, BARBARA, STAMM, WALTER E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 225
container_issue 4
container_start_page 219
container_title Sexually transmitted diseases
container_volume 28
creator MARRAZZO, JEANNE M.
WHITTINGTON, WILLIAM L. H.
CELUM, CONNIE L.
HANDSFIELD, H. HUNTER
CLARK, AGNES
CLES, LINDA
KREKELER, BARBARA
STAMM, WALTER E.
description Background: Nucleic acid-amplified tests for Chlamydia trachomatis are accurate but costly. Screening strategies for asymptomatic men are needed. Goal: To assess C trachomatis screening strategies for asymptomatic males. Study Design: Men attending a sexually transmitted disease clinic were tested for C trachomatis with ligase chain reaction and culture, and for urethral inflammation with urine leukocyte esterase and urethral Gram stain. Results: C trachomatis prevalence was 5.5% among 1,625 asymptomatic men. Ligase chain reaction increased detection by 49% among men without urethral inflammation. An age of younger than 25 years and urethral inflammation were associated with positive ligase chain reaction results. The negative predictive value of urine leukocyte esterase was highest among older men, but urethral Gram stain was equally sensitive in predicting infection regardless of age. An age of younger than 30 years or urethral inflammation identified the highest proportion of infections (92%) and reduced the percentage of men screened by 43%. Conclusions: Urine ligase chain reaction increased C trachomatis detection, particularly among men without urethral inflammation. Testing all asymptomatic men younger than 30 years is optimal, whereas negative urine leukocyte esterase or urethral Gram stain results in men 30 years or older support no testing.
doi_str_mv 10.1097/00007435-200104000-00006
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_70782740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>44965465</jstor_id><sourcerecordid>44965465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-d6d86ed0f6256a67225a896554941b372347f758b9651ef0b0275059c8fc32593</originalsourceid><addsrcrecordid>eNpdkU9P3DAQxa2Kqiy0H6HIQiq3tOP_yRG20CIt6mGXc-R1JsWrxAE7kdhvXy-7BQlfrHnzm9HoPUIog-8MKvMD8jNSqIIDMJC5KnaS_kBmTAlTSMXZEZkBk2WhDDPH5CSlDexqYJ_IMWOClVyJGcH76AMWVzZhQ5cuIgYf_tJ2iHT-0Nl-23hLx2jdw9Db0SfqA73DQC_HEUOzQ5f4PNmu29JVtCH1Pjca-tMnzCvpvPPBu_SZfGxtl_DL4T8l9zfXq_nvYvHn1-38clE4KWEsGt2UGhtoNVfaasO5smWllZKVZGthuJCmNapcZ41hC2vgRoGqXNk6wVUlTsnFfu9jHJ4mTGPd--Sw62zAYUq1AVNyIyGD5-_AzTDFkG-rOefCCC5Zhso95OKQUsS2foy-t3FbM6h3OdT_c6hfc3iRdB49O-yf1j02b4MH4zPw7QDY5GzXZu-cT2-ckKArzTP3dc9t0jjE176U2QKplfgHuM2Xjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222373241</pqid></control><display><type>article</type><title>Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>JSTOR Archive Collection A-Z Listing</source><creator>MARRAZZO, JEANNE M. ; WHITTINGTON, WILLIAM L. H. ; CELUM, CONNIE L. ; HANDSFIELD, H. HUNTER ; CLARK, AGNES ; CLES, LINDA ; KREKELER, BARBARA ; STAMM, WALTER E.</creator><creatorcontrib>MARRAZZO, JEANNE M. ; WHITTINGTON, WILLIAM L. H. ; CELUM, CONNIE L. ; HANDSFIELD, H. HUNTER ; CLARK, AGNES ; CLES, LINDA ; KREKELER, BARBARA ; STAMM, WALTER E.</creatorcontrib><description>Background: Nucleic acid-amplified tests for Chlamydia trachomatis are accurate but costly. Screening strategies for asymptomatic men are needed. Goal: To assess C trachomatis screening strategies for asymptomatic males. Study Design: Men attending a sexually transmitted disease clinic were tested for C trachomatis with ligase chain reaction and culture, and for urethral inflammation with urine leukocyte esterase and urethral Gram stain. Results: C trachomatis prevalence was 5.5% among 1,625 asymptomatic men. Ligase chain reaction increased detection by 49% among men without urethral inflammation. An age of younger than 25 years and urethral inflammation were associated with positive ligase chain reaction results. The negative predictive value of urine leukocyte esterase was highest among older men, but urethral Gram stain was equally sensitive in predicting infection regardless of age. An age of younger than 30 years or urethral inflammation identified the highest proportion of infections (92%) and reduced the percentage of men screened by 43%. Conclusions: Urine ligase chain reaction increased C trachomatis detection, particularly among men without urethral inflammation. Testing all asymptomatic men younger than 30 years is optimal, whereas negative urine leukocyte esterase or urethral Gram stain results in men 30 years or older support no testing.</description><identifier>ISSN: 0148-5717</identifier><identifier>EISSN: 1537-4521</identifier><identifier>DOI: 10.1097/00007435-200104000-00006</identifier><identifier>PMID: 11318253</identifier><identifier>CODEN: STRDDM</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Age Factors ; Bacterial diseases ; Bacterial diseases of the genital system ; Biological and medical sciences ; Carboxylic Ester Hydrolases - urine ; Chlamydia Infections - diagnosis ; Chlamydia Infections - epidemiology ; Chlamydia Infections - urine ; Chlamydia trachomatis - isolation &amp; purification ; Clinics ; Gentian Violet ; Human bacterial diseases ; Humans ; Infectious diseases ; Ligase Chain Reaction - methods ; Male ; Mass Screening - methods ; Mass Screening - standards ; Medical sciences ; Medical screening ; Men ; Phenazines ; Predictive Value of Tests ; Prevalence ; Sensitivity and Specificity ; Sexually transmitted diseases ; STD ; Urethra - microbiology ; Urethritis - microbiology ; Urine</subject><ispartof>Sexually transmitted diseases, 2001-04, Vol.28 (4), p.219-225</ispartof><rights>Copyright © 2001 American Sexually Transmitted Diseases Association</rights><rights>2002 INIST-CNRS</rights><rights>Copyright Lippincott Williams &amp; Wilkins Apr 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-d6d86ed0f6256a67225a896554941b372347f758b9651ef0b0275059c8fc32593</citedby><cites>FETCH-LOGICAL-c440t-d6d86ed0f6256a67225a896554941b372347f758b9651ef0b0275059c8fc32593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/44965465$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/44965465$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,30999,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13406962$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11318253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MARRAZZO, JEANNE M.</creatorcontrib><creatorcontrib>WHITTINGTON, WILLIAM L. H.</creatorcontrib><creatorcontrib>CELUM, CONNIE L.</creatorcontrib><creatorcontrib>HANDSFIELD, H. HUNTER</creatorcontrib><creatorcontrib>CLARK, AGNES</creatorcontrib><creatorcontrib>CLES, LINDA</creatorcontrib><creatorcontrib>KREKELER, BARBARA</creatorcontrib><creatorcontrib>STAMM, WALTER E.</creatorcontrib><title>Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics</title><title>Sexually transmitted diseases</title><addtitle>Sex Transm Dis</addtitle><description>Background: Nucleic acid-amplified tests for Chlamydia trachomatis are accurate but costly. Screening strategies for asymptomatic men are needed. Goal: To assess C trachomatis screening strategies for asymptomatic males. Study Design: Men attending a sexually transmitted disease clinic were tested for C trachomatis with ligase chain reaction and culture, and for urethral inflammation with urine leukocyte esterase and urethral Gram stain. Results: C trachomatis prevalence was 5.5% among 1,625 asymptomatic men. Ligase chain reaction increased detection by 49% among men without urethral inflammation. An age of younger than 25 years and urethral inflammation were associated with positive ligase chain reaction results. The negative predictive value of urine leukocyte esterase was highest among older men, but urethral Gram stain was equally sensitive in predicting infection regardless of age. An age of younger than 30 years or urethral inflammation identified the highest proportion of infections (92%) and reduced the percentage of men screened by 43%. Conclusions: Urine ligase chain reaction increased C trachomatis detection, particularly among men without urethral inflammation. Testing all asymptomatic men younger than 30 years is optimal, whereas negative urine leukocyte esterase or urethral Gram stain results in men 30 years or older support no testing.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the genital system</subject><subject>Biological and medical sciences</subject><subject>Carboxylic Ester Hydrolases - urine</subject><subject>Chlamydia Infections - diagnosis</subject><subject>Chlamydia Infections - epidemiology</subject><subject>Chlamydia Infections - urine</subject><subject>Chlamydia trachomatis - isolation &amp; purification</subject><subject>Clinics</subject><subject>Gentian Violet</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Ligase Chain Reaction - methods</subject><subject>Male</subject><subject>Mass Screening - methods</subject><subject>Mass Screening - standards</subject><subject>Medical sciences</subject><subject>Medical screening</subject><subject>Men</subject><subject>Phenazines</subject><subject>Predictive Value of Tests</subject><subject>Prevalence</subject><subject>Sensitivity and Specificity</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Urethra - microbiology</subject><subject>Urethritis - microbiology</subject><subject>Urine</subject><issn>0148-5717</issn><issn>1537-4521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNpdkU9P3DAQxa2Kqiy0H6HIQiq3tOP_yRG20CIt6mGXc-R1JsWrxAE7kdhvXy-7BQlfrHnzm9HoPUIog-8MKvMD8jNSqIIDMJC5KnaS_kBmTAlTSMXZEZkBk2WhDDPH5CSlDexqYJ_IMWOClVyJGcH76AMWVzZhQ5cuIgYf_tJ2iHT-0Nl-23hLx2jdw9Db0SfqA73DQC_HEUOzQ5f4PNmu29JVtCH1Pjca-tMnzCvpvPPBu_SZfGxtl_DL4T8l9zfXq_nvYvHn1-38clE4KWEsGt2UGhtoNVfaasO5smWllZKVZGthuJCmNapcZ41hC2vgRoGqXNk6wVUlTsnFfu9jHJ4mTGPd--Sw62zAYUq1AVNyIyGD5-_AzTDFkG-rOefCCC5Zhso95OKQUsS2foy-t3FbM6h3OdT_c6hfc3iRdB49O-yf1j02b4MH4zPw7QDY5GzXZu-cT2-ckKArzTP3dc9t0jjE176U2QKplfgHuM2Xjw</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>MARRAZZO, JEANNE M.</creator><creator>WHITTINGTON, WILLIAM L. H.</creator><creator>CELUM, CONNIE L.</creator><creator>HANDSFIELD, H. HUNTER</creator><creator>CLARK, AGNES</creator><creator>CLES, LINDA</creator><creator>KREKELER, BARBARA</creator><creator>STAMM, WALTER E.</creator><general>Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics</title><author>MARRAZZO, JEANNE M. ; WHITTINGTON, WILLIAM L. H. ; CELUM, CONNIE L. ; HANDSFIELD, H. HUNTER ; CLARK, AGNES ; CLES, LINDA ; KREKELER, BARBARA ; STAMM, WALTER E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-d6d86ed0f6256a67225a896554941b372347f758b9651ef0b0275059c8fc32593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the genital system</topic><topic>Biological and medical sciences</topic><topic>Carboxylic Ester Hydrolases - urine</topic><topic>Chlamydia Infections - diagnosis</topic><topic>Chlamydia Infections - epidemiology</topic><topic>Chlamydia Infections - urine</topic><topic>Chlamydia trachomatis - isolation &amp; purification</topic><topic>Clinics</topic><topic>Gentian Violet</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Ligase Chain Reaction - methods</topic><topic>Male</topic><topic>Mass Screening - methods</topic><topic>Mass Screening - standards</topic><topic>Medical sciences</topic><topic>Medical screening</topic><topic>Men</topic><topic>Phenazines</topic><topic>Predictive Value of Tests</topic><topic>Prevalence</topic><topic>Sensitivity and Specificity</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Urethra - microbiology</topic><topic>Urethritis - microbiology</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MARRAZZO, JEANNE M.</creatorcontrib><creatorcontrib>WHITTINGTON, WILLIAM L. H.</creatorcontrib><creatorcontrib>CELUM, CONNIE L.</creatorcontrib><creatorcontrib>HANDSFIELD, H. HUNTER</creatorcontrib><creatorcontrib>CLARK, AGNES</creatorcontrib><creatorcontrib>CLES, LINDA</creatorcontrib><creatorcontrib>KREKELER, BARBARA</creatorcontrib><creatorcontrib>STAMM, WALTER E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Sexually transmitted diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MARRAZZO, JEANNE M.</au><au>WHITTINGTON, WILLIAM L. H.</au><au>CELUM, CONNIE L.</au><au>HANDSFIELD, H. HUNTER</au><au>CLARK, AGNES</au><au>CLES, LINDA</au><au>KREKELER, BARBARA</au><au>STAMM, WALTER E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics</atitle><jtitle>Sexually transmitted diseases</jtitle><addtitle>Sex Transm Dis</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>28</volume><issue>4</issue><spage>219</spage><epage>225</epage><pages>219-225</pages><issn>0148-5717</issn><eissn>1537-4521</eissn><coden>STRDDM</coden><abstract>Background: Nucleic acid-amplified tests for Chlamydia trachomatis are accurate but costly. Screening strategies for asymptomatic men are needed. Goal: To assess C trachomatis screening strategies for asymptomatic males. Study Design: Men attending a sexually transmitted disease clinic were tested for C trachomatis with ligase chain reaction and culture, and for urethral inflammation with urine leukocyte esterase and urethral Gram stain. Results: C trachomatis prevalence was 5.5% among 1,625 asymptomatic men. Ligase chain reaction increased detection by 49% among men without urethral inflammation. An age of younger than 25 years and urethral inflammation were associated with positive ligase chain reaction results. The negative predictive value of urine leukocyte esterase was highest among older men, but urethral Gram stain was equally sensitive in predicting infection regardless of age. An age of younger than 30 years or urethral inflammation identified the highest proportion of infections (92%) and reduced the percentage of men screened by 43%. Conclusions: Urine ligase chain reaction increased C trachomatis detection, particularly among men without urethral inflammation. Testing all asymptomatic men younger than 30 years is optimal, whereas negative urine leukocyte esterase or urethral Gram stain results in men 30 years or older support no testing.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>11318253</pmid><doi>10.1097/00007435-200104000-00006</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0148-5717
ispartof Sexually transmitted diseases, 2001-04, Vol.28 (4), p.219-225
issn 0148-5717
1537-4521
language eng
recordid cdi_proquest_miscellaneous_70782740
source MEDLINE; Journals@Ovid Complete; Applied Social Sciences Index & Abstracts (ASSIA); JSTOR Archive Collection A-Z Listing
subjects Adult
Age Factors
Bacterial diseases
Bacterial diseases of the genital system
Biological and medical sciences
Carboxylic Ester Hydrolases - urine
Chlamydia Infections - diagnosis
Chlamydia Infections - epidemiology
Chlamydia Infections - urine
Chlamydia trachomatis - isolation & purification
Clinics
Gentian Violet
Human bacterial diseases
Humans
Infectious diseases
Ligase Chain Reaction - methods
Male
Mass Screening - methods
Mass Screening - standards
Medical sciences
Medical screening
Men
Phenazines
Predictive Value of Tests
Prevalence
Sensitivity and Specificity
Sexually transmitted diseases
STD
Urethra - microbiology
Urethritis - microbiology
Urine
title Urine-Based Screening for Chlamydia trachomatis in Men Attending Sexually Transmitted Disease Clinics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T18%3A53%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urine-Based%20Screening%20for%20Chlamydia%20trachomatis%20in%20Men%20Attending%20Sexually%20Transmitted%20Disease%20Clinics&rft.jtitle=Sexually%20transmitted%20diseases&rft.au=MARRAZZO,%20JEANNE%20M.&rft.date=2001-04-01&rft.volume=28&rft.issue=4&rft.spage=219&rft.epage=225&rft.pages=219-225&rft.issn=0148-5717&rft.eissn=1537-4521&rft.coden=STRDDM&rft_id=info:doi/10.1097/00007435-200104000-00006&rft_dat=%3Cjstor_proqu%3E44965465%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222373241&rft_id=info:pmid/11318253&rft_jstor_id=44965465&rfr_iscdi=true